In the News

FDA Clears Eko’s AI for Detecting Heart Disease

Eko receives FDA clearance for Eko Murmur Analysis Software (EMAS).
July 12, 2022

Eko announced today that it received FDA clearance for its Eko Murmur Analysis Software (EMAS) for adult and pediatric patients.

The next generation of Eko’s murmur detection capabilities, EMAS represents the first and only smart stethoscope on the market that can identify and differentiate between innocent and structural heart murmurs indicative of valvular heart disease.

Read more at MassDevice